We found that miR-10a/b-5p induces the growth of ICC and pancreatic β cells by targeting KLF11 (a causative gene for maturity-onset of diabetes of the young), which negatively regulates expression of KIT and insulin (INS) genes. This evidence concerns the gene KIT and intrahepatic cholangiocarcinoma.